e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
COPD: experimental biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes of alveolar oxygen tension in chronic obstructive pulmonary disease (COPD) and effect of variable oxygen tension on hypoxia inducible factor (HIF)-1alpha system of alveolar epithelial cells
B. Odler, E. Sziksz, L. Himer, G. Horvath, A. Onody, A. Vannay, G. Losonczy, A. J. Szabo, V. Muller (Budapest, Hungary)
Source:
Annual Congress 2013 –COPD: experimental biology
Session:
COPD: experimental biology
Session type:
Thematic Poster Session
Number:
623
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Odler, E. Sziksz, L. Himer, G. Horvath, A. Onody, A. Vannay, G. Losonczy, A. J. Szabo, V. Muller (Budapest, Hungary). Changes of alveolar oxygen tension in chronic obstructive pulmonary disease (COPD) and effect of variable oxygen tension on hypoxia inducible factor (HIF)-1alpha system of alveolar epithelial cells. Eur Respir J 2013; 42: Suppl. 57, 623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002
Resistance of quiescent and proliferating airway epithelial cells to H2O2 challenge
Source: Eur Respir J 2007; 29: 633-642
Year: 2007
Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Hypoxia inducible factor-1? in human emphysema lung tissue
Source: Eur Respir J 2011; 37: 775-783
Year: 2011
Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012
The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Pulmonary vascular involvement in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 28S-32S
Year: 2003
Cytokine-mediated reactive oxygen species hyperproduction in the airway inflammation of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 435s
Year: 2004
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Increased small intestinal permeability during severe acute exacerbations of COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Diffusion capacity and CT measures of emphysema and airway wall thickness - Relation to arterial oxygen tension in COPD patients
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms
Source: Eur Respir J 2008; 32: 1639-1651
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept